Skip to main content

Want a detailed portfolio tracker?

AMRZ
NYSE
$48.69

Amrize Ltd (AMRZ)

Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.
Website: https://www.amrize.com
68 analysts
Buy
Target: $63.16 (+29.73%)

Market Cap

$28B

Forward P/E

17.39

P/E Ratio

24.28

Free Cash Flow Yield

4.70%

Price Chart

Valuation
Market Cap$28B
P/E24.28
Forward P/E17.39
PEG1.34
P/S2.36
P/B2.10
Profitability
Total Revenue (TTM)$12B
Gross Profit (TTM)$3.02B
EBITDA$2.62B
Profit Margin-5.3%
Operating Margin-3.5%
EPS$2.09
Financial Health
Debt-to-Equity40.2%
Free Cash Flow Yield4.70%
Dividend Yield0.86%
Growth & Risk
Beta (5Y)1.30
Sharpe Ratio0.01